These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1772748)

  • 21. Scleroderma--pathophysiology.
    Yamamoto T
    Eur J Dermatol; 2009; 19(1):14-24. PubMed ID: 19059831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma).
    Niks M; Rovenský J; Nyulassy S; Buc M; Stefanovic J; Zitnan D
    Tissue Antigens; 1982 Mar; 19(3):238-9. PubMed ID: 6953619
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
    Johanet C; Agostini MM; Vayssairat M; Abuaf N
    Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of DM genes in systemic sclerosis is secondary to the association with HLA genes.
    Takeuchi F; Takizawa K; Nabeta H; Kuwata S; Ito K
    Scand J Rheumatol; 1997; 26(3):174-9. PubMed ID: 9225871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic factors in scleroderma.
    Briggs D; Black C; Welsh K
    Rheum Dis Clin North Am; 1990 Feb; 16(1):31-51. PubMed ID: 2406810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradermal Injections of Bleomycin to Model Skin Fibrosis.
    Yamamoto T
    Methods Mol Biol; 2017; 1627():43-47. PubMed ID: 28836193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic studies of environmental agents and systemic autoimmune diseases.
    Mayes MD
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):743-8. PubMed ID: 10502540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunogenetic background of scleroderma--an overview.
    Black C; Briggs D; Welsh K
    Clin Exp Dermatol; 1992 Mar; 17(2):73-8. PubMed ID: 1516246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetics in systemic sclerosis].
    Skretkowicz J; Skretkowicz-Szarmach K
    Pol Merkur Lekarski; 2006 Jan; 20(115):117-20. PubMed ID: 16617751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fc gamma RII restriction fragment length polymorphism (RFLP): analysis in systemic lupus erythematosus and scleroderma and evidence of an alpha gene duplication.
    Jazwinska EC; Olive C; Hogarth PM; Gatenby PA; Serjeantson SW
    Clin Exp Immunol; 1991 Jan; 83(1):47-51. PubMed ID: 1671005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial cases of scleroderma].
    Dobzhanskiĭ SI
    Vestn Dermatol Venerol; 1979 May; (5):40-2. PubMed ID: 452677
    [No Abstract]   [Full Text] [Related]  

  • 32. Animal models of scleroderma: fresh insights.
    Artlett CM
    Curr Opin Rheumatol; 2010 Nov; 22(6):677-82. PubMed ID: 20720495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in animal models of systemic sclerosis.
    Asano Y
    J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of scleroderma.
    Black CM; Welsh KI
    Clin Dermatol; 1994; 12(3):337-47. PubMed ID: 7954192
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.
    Tsujino K; Sheppard D
    Curr Rheumatol Rep; 2016 Jan; 18(1):4. PubMed ID: 26711695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic control of avian scleroderma.
    Abplanalp H; Gershwin ME; Johnston E; Reid J
    Immunogenetics; 1990; 31(5-6):291-5. PubMed ID: 2370076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients.
    Needleman BW
    Arthritis Rheum; 1990 Dec; 33(12):1847-51. PubMed ID: 1979737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Scleroderma and HLA antigens].
    Holzmann H; Sollberg S; Schütz K; Kühnl P
    Hautarzt; 1989 Mar; 40(3):134-40. PubMed ID: 2714991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.